This innovative formulation builds on its unique mechanism of action and on research into topical ketamine, which has been used in compounded pain creams but lacks the bioavailability, consistency ...

The global topical pain relief market was valued at $8,864.0 million in 2019, and is projected to reach $12,219.7 million by 2027 at a CAGR of 5.2% from 2020 to 2027. Increase in prevalence of ...

"The development of both an oral and topical formulation of Ketamir-2 significantly ... lidocaine patches, capsaicin creams, gabapentin, pregabalin, and opioids-offer limited relief and come ...